Aspire Biopharma Holdings Accounts Payable

Aspire Biopharma Holdings (ASBP) currently reports a accounts payable of $970K as of June 2026. That compares with $1.4M in the prior-year period — down 28.1% year over year. Use the charts on this page to explore Aspire Biopharma Holdings's accounts payable history and peer comparisons.

Aspire Biopharma Holdings's accounts payable decreased from $1.4M to $970K — a 28.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspire Biopharma Holdings reported $970K in accounts payable as of June 2026. That compares with $1.4M in the prior-year period — down 28.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $970K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspire Biopharma Holdings, and consider following ASBP for alerts when major investors trade the stock.